67
Participants
Start Date
September 30, 2010
Primary Completion Date
June 30, 2013
Study Completion Date
December 31, 2013
Ziprasidone
100% of the past antipsychotic dose will be maintained in week 1, using flexible dosing of 0-100% during next 3 weeks and then discontinued. Ziprasidone will be maintained with flexible dosing of 40-160mg/day during the study period.
Korea University Medical Center Ansan Hospital, Ansan
Soonchunhyang University Bucheon Hospital, Bucheon-si
Inha University Hospital, Incheon
Catholic University Our Lady of Mercy Hospital, Incheon
Korea University Medical Center Guro Hospital, Seoul
Kangnam Sacred Heart Hospital, Seoul
Collaborators (1)
Pfizer
INDUSTRY
Soonchunhyang University Hospital
OTHER